Medicines 
Dealstreet

Samisti Legal, Trilegal act on Piramal Pharma acquiring minority stake in Yapan Bio for ₹101.77 crore

The acquisition took place through primary and secondary purchase of shares.

Bar & Bench

Piramal Pharma acquires minority stake in Yapan Bio for ₹101.77 crore.

Samisti Legal acted as the legal counsel to Yapan Bio. The team was led by Prashant Jain (Partner) and assisted by Anita Dugar (Principal Associate).

Trilegal acted for Piramal Pharma.

The investment will allow Piramal Pharma to strengthen Piramal Pharma Solutions (PPS), its Contract Development and Manufacturing Organization (CDMO) business, by broadening its service offerings.

The acquisition took place through primary and secondary purchase of shares.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Whitefield police station should be renamed darkfield: Karnataka HC flags repeated violation of arrest guidelines

Bombay High Court pulls up FDA for 'high-handed' cancellation of Cipla drug licences

Not a single life should be lost: Bombay High Court orders medical care for fasting tribal students

Bombay HC suggests restaurants maintain websites, social media handles to facilitate feedback on food hygiene

Take appointment of arbitrators away from parties, institutionalise process: Shashank Garg

SCROLL FOR NEXT